Federico Grossi
2021
In 2021, Federico Grossi earned a total compensation of $2.6M as Chief Medical Officer at Apellis Pharmaceuticals.
Compensation breakdown
| Bonus | $140,800 |
|---|---|
| Option Awards | $1,617,188 |
| Salary | $436,539 |
| Stock Awards | $420,938 |
| Other | $674 |
| Total | $2,616,139 |
Grossi received $1.6M in option awards, accounting for 62% of the total pay in 2021.
Grossi also received $140.8K in bonus, $436.5K in salary, $420.9K in stock awards and $674 in other compensation.
Rankings
In 2021, Federico Grossi's compensation ranked 4,981st out of 12,415 executives tracked by ExecPay. In other words, Grossi earned more than 59.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,981 out of 12,415 | 60th |
Division Manufacturing | 2,097 out of 5,508 | 62nd |
Major group Chemicals And Allied Products | 897 out of 2,378 | 62nd |
Industry group Drugs | 802 out of 2,099 | 62nd |
Industry Pharmaceutical Preparations | 571 out of 1,549 | 63rd |
Pay ratio
| Federico Grossi's Pay | $2,616,139 |
|---|---|
| Median Employee's Pay | $321,867 |
| Pay Ratio | 8to 1 |
In 2021, the annual total compensation of Federico Grossi was $2,616,139.
The annual total compensation of the median employee at Apellis Pharmaceuticals was $321,867.
The ratio of Federico Grossi's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on April 20, 2022.
Grossi's colleagues
We found four more compensation records of executives who worked with Federico Grossi at Apellis Pharmaceuticals in 2021.